These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 37818354)

  • 1. Monitoring regulatory T cells as a prognostic marker in lung transplantation.
    Khan MA; Lau CL; Krupnick AS
    Front Immunol; 2023; 14():1235889. PubMed ID: 37818354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome.
    Bhorade SM; Chen H; Molinero L; Liao C; Garrity ER; Vigneswaran WT; Shilling R; Sperling A; Chong A; Alegre ML
    Transplantation; 2010 Sep; 90(5):540-6. PubMed ID: 20628341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation.
    Krustrup D; Iversen M; Martinussen T; Schultz HH; Andersen CB
    Clin Transplant; 2015 Mar; 29(3):179-84. PubMed ID: 25533723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
    Benden C; Haughton M; Leonard S; Huber LC
    J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
    Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When tissue is the issue: A histological review of chronic lung allograft dysfunction.
    Verleden SE; Von der Thüsen J; Roux A; Brouwers ES; Braubach P; Kuehnel M; Laenger F; Jonigk D
    Am J Transplant; 2020 Oct; 20(10):2644-2651. PubMed ID: 32185874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against bronchiolitis obliterans syndrome is associated with allograft CCR7+ CD45RA- T regulatory cells.
    Gregson AL; Hoji A; Palchevskiy V; Hu S; Weigt SS; Liao E; Derhovanessian A; Saggar R; Song S; Elashoff R; Yang OO; Belperio JA
    PLoS One; 2010 Jun; 5(6):e11354. PubMed ID: 20613873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.
    Sundaresan S; Trulock EP; Mohanakumar T; Cooper JD; Patterson GA
    Ann Thorac Surg; 1995 Nov; 60(5):1341-6; discussion 1346-7. PubMed ID: 8526624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory and Effector Cell Disequilibrium in Patients with Acute Cellular Rejection and Chronic Lung Allograft Dysfunction after Lung Transplantation: Comparison of Peripheral and Alveolar Distribution.
    Bergantini L; d'Alessandro M; De Vita E; Perillo F; Fossi A; Luzzi L; Paladini P; Perrone A; Rottoli P; Sestini P; Bargagli E; Bennett D
    Cells; 2021 Apr; 10(4):. PubMed ID: 33916034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction.
    Kaza V; Zhu C; Terada LS; Wang L; Torres F; Bollineni S; Mohanka M; Banga A; Joerns J; Mohanakumar T; Li QZ
    Hum Immunol; 2021 Jan; 82(1):25-35. PubMed ID: 33129576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity.
    Todd JL; Wang X; Sugimoto S; Kennedy VE; Zhang HL; Pavlisko EN; Kelly FL; Huang H; Kreisel D; Palmer SM; Gelman AE
    Am J Respir Crit Care Med; 2014 Mar; 189(5):556-66. PubMed ID: 24471427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?
    Hadjiliadis D; Davis RD; Palmer SM
    Chest; 2002 Oct; 122(4):1168-75. PubMed ID: 12377838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
    Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
    Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.
    Martinu T; Oishi H; Juvet SC; Cypel M; Liu M; Berry GJ; Hwang DM; Keshavjee S
    Am J Transplant; 2019 Jan; 19(1):247-258. PubMed ID: 30378739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Checkpoints Expression in Chronic Lung Allograft Rejection.
    Righi I; Vaira V; Morlacchi LC; Croci GA; Rossetti V; Blasi F; Ferrero S; Nosotti M; Rosso L; Clerici M
    Front Immunol; 2021; 12():714132. PubMed ID: 34489963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are we near to an effective drug treatment for bronchiolitis obliterans?
    Verleden GM; Vos R; Dupont L; Van Raemdonck DE; Vanaudenaerde BM; Verleden SE
    Expert Opin Pharmacother; 2014 Oct; 15(15):2117-20. PubMed ID: 25154562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
    Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
    Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood CD9
    Brosseau C; Danger R; Durand M; Durand E; Foureau A; Lacoste P; Tissot A; Roux A; Reynaud-Gaubert M; Kessler R; Mussot S; Dromer C; Brugière O; Mornex JF; Guillemain R; Claustre J; Magnan A; Brouard S;
    Am J Transplant; 2019 Nov; 19(11):3162-3175. PubMed ID: 31305014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
    Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
    Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies in lung transplantation.
    Sureshbabu A; Fleming T; Mohanakumar T
    Transpl Int; 2020 Jan; 33(1):41-49. PubMed ID: 31393646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.